Sino Biopharmaceutic (SBMFF) 0.7690 $SBMFF WuXi AppTec

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sino Biopharmaceutic (SBMFF) 0.7690 $SBMFF

WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement
PR Newswire - Fri Jan 08, 7:00AM CST
WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and medical device industries, today congratulated Chia Tai Tianqing Pharmaceutical Group Co. Ltd. (CTTQ), a well-established Chinese pharmaceutical company that is a subsidiary of Sino Biopharmaceutical Ltd., and Janssen Pharmaceuticals Inc. (Janssen), a leading global pharmaceutical company, for having reached an exclusive license agreement. Under this agreement, CTTQ grants Janssen rights to develop and commercialize an undisclosed immuno-modulating agent to treat chronic hepatitis B virus (HBV) infection globally outside China. Both CTTQ and Janssen are long-time collaboration partners of WuXi. In 2013, CTTQ signed a contract with WuXi to discover anti-HBV small-molecule drugs. WuXi provided end-to-end integrated research services on the compound that is the subject of this license agreement.

LifeBond Closes $27 Million Series D Financing Round
PR Newswire - Wed Aug 05, 6:15AM CDT
LifeBond, a leader in the development of bio-surgical medical devices for tissue repair, announced today it has closed a $27M Series D preferred equity investment. Participants in the round include Pitango Venture Capital, Adams Street Partners, Sino Biopharmaceutical Ltd., and all existing investors.

Medullary Thyroid Cancer - Global Clinical Trials Review, H1, 2015
M2 - Mon Jul 27, 5:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ldtm6m/medullary_thyroid) has announced the addition of the "Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" report to their offering. "Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Medullary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Medullary Thyroid Cancer. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies/Institutions Participating in Medullary Thyroid Cancer Therapeutics Clinical Trials - AstraZeneca PLC - Exelixis, Inc. - Eisai Co., Ltd. - Sino Biopharmaceutical Limited - Sanofi - Immunomedics, Inc. - Globeimmune, Inc. - EANM Research Ltd. - Bayer AG - Amgen Inc. - National Cancer Institute - University of Kentucky - University of Wisconsin Madison - Garden State Cancer Center - University of Texas M. D. Anderson Cancer Center - University of Southern California - Sidney Kimmel Comprehensive Cancer Center - University of Washington - Medical University of Vienna - Leiden University Medical Center For more information visit http://www.researchandmarkets.com/research/ld...ry_thyroid
IMMU: 2.28 (+0.08), AZN: 30.24 (-0.10), AMGN: 163.28 (+0.54), EXEL: 8.44 (+0.22)

Medullary Thyroid Cancer Therapeutics Clinical Trials Market Review H1 2015 Available at RnRMarketResearch.com
PRWeb - Thu Apr 30, 6:31AM CDT
The report "Medullary Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides elemental information and data relating to the clinical trials on Medullary Thyroid Cancer. Complete report on H1 2015 Clinical Trials review of "Medullary Thyroid Cancer" addiction with 44 market data tables and 109 figures, spread across 65 pages is available at http://www.rnrmarketresearch.com/medullary-th...eport.html .
IMMU: 2.28 (+0.08), EXEL: 8.44 (+0.22)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 9

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 10

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Community Banks Missing $106B Lending Opportunity?

Updated Category News Views 18

A Missed Opportunity for Community Banks It's a classic tale: community banks sleepwalking while big players snatch up low-hanging fruit right in their own backyards. According to the latest report by Cornerstone Advisors, commissioned by Teslar Software, these banks are essentially leaving $106 billion on the table when it comes to consumer lending. That's not just chump...

Continue Reading
NYSE Texas Redefines the U.S. Capital Markets Landscape

Updated Category News Views 16

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Continue Reading
Cala Launches Game-Changer Wearable for Tremor Relief

Updated Category News Views 10

Breaking New Ground in Neuromodulation Medical tech's on a roll, and Cala Health just hopped on the fast track with their latest launch—the Cala kIQ Plus System. This bad boy is aiming to offer relief for those grappling with hand tremors, thanks to its FDA clearance and a host of new features. It's the first of its kind, combining multiple therapy modes with an...

Continue Reading
Dentistry.One Achieves HITRUST i1, Boosts Cybertrust

Updated Category News Views 9

HITRUST i1 Certification: The Gold Standard in Security For a world increasingly reliant on digital infrastructure, cybersecurity certification is no longer just a badge of honor; it's a cornerstone of trust. Dentistry.One nailed this down by bagging that coveted HITRUST i1 certification. When folks talk about securing data, HITRUST might as well be speaking gospel. We're...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 11

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
JiMMYBAR! Expands Creatine Market with Target Launch

Updated Category News Views 17

JiMMYBAR! Breaks New Ground in Supplements You ever notice how some companies just know how to shake things up? Take JiMMYBAR!, for instance. The moment I read they’re making moves to get their Creatine + Protein bars into Target stores nationwide, starting October 4, I thought, “That’s one way to drag creatine out from the dusty tub and onto the shelves of...

Continue Reading
Karoo Health Leaps Forward with New CCO Breton

Updated Category News Views 12

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Continue Reading
ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 10

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading

Top 5 Most Recently Viewed Articles

Centrus Energy's Upcoming Conference Call: What to Expect

Updated Category News Views 150

Upcoming Conference Call by Centrus Energy Corp. Centrus Energy Corp. (NYSE American: LEU) is set to engage with shareholders and the financial community during its quarterly conference call on February 7, 2025, at 8:30 a.m. ET. This call offers vital insights into the company's financial performance and future direction. Details of the Earnings Report During this call,...

Continue Reading
Century Communities Posts Record 2024 Results and Outlook

Updated Category News Views 350

Century Communities Reports Impressive 2024 Performance Century Communities, Inc. (NYSE: CCS), a prominent player in the homebuilding industry, has declared remarkable financial results for the fourth quarter and full year of 2024. The company achieved record net income and significant year-over-year growth across key metrics. Fourth Quarter Highlights The fourth quarter...

Continue Reading
Yamaha Guitars: Celebrating 60 Years of Innovation and Craft

Updated Category News Views 107

Yamaha Guitars Commemorates 60 Years of Excellence Yamaha has reached a remarkable milestone as it celebrates 60 years in guitar manufacturing, showcasing their dedication to artistry and innovation in the music industry. This celebration was announced at The NAMM Show 2026, where Yamaha introduced brand new products and honored its legacy. This year’s festivities...

Continue Reading
Innovative Fundraising: GCU's Commitment to Community Growth

Updated Category News Views 412

GCU's Revolutionary Fundraising Campaign: A Community-Centric Approach Grand Canyon University (NASDAQ: GCU) is embracing an extraordinary approach to fundraising, one that emphasizes community revitalization over traditional university needs. This initiative marks a significant transition for the university that resumed its nonprofit status in 2018. The campaign is set...

Continue Reading
Montreal's Innovative Modular Housing Project for the Homeless

Updated Category News Views 263

Montreal's Innovative Modular Housing Project The City of Montreal has achieved a significant milestone by launching its first modular housing project aimed at addressing homelessness. This initiative provides essential support services to offer a sustainable solution for vulnerable individuals, demonstrating a commitment to tackling the homelessness crisis effectively....

Continue Reading